Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

         
Total article views   Abstract views HTML views PDF downloads Totals
10,105 Dovepress* 5,808 2,701+ 1,934 8,509
PubMed Central* 0 1,596 514 1,596
Totals 5,808 4,297 2,448 10,105
*Since 17 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar